Subscribe to RSS
DOI: 10.1055/a-2004-0041
Forty-Eight Hour Ex Vivo Perfusion and Two-Hour Simulated Reperfusion after a Major Traumatic Upper Extremity Amputation
Abstract
Background Extremity replantation as well as allotransplantation aim to restore form and function of the amputated limb. Both approaches, however, are clearly limited by the ischemic time. Ex vivo perfusion (EVP), already well-established in the field of solid organ transplantation, represents a promising tool to overcome this restriction.
Methods We have currently established the technical requirements to provide EVP to severed limbs in a clinical hospital setting and hereby report of a 48-hour hypothermic EVP (EVP48) of an upper extremity amputated at the level of the proximal humerus, followed by a 2-hour simulated reperfusion (2SR) with donor blood.
Results Muscle biopsies revealed histopathologically well preserved, vital muscle tissue after EVP24, and partially grouped muscle fiber necrosis with predominantly vital muscle tissue after EVP48 and 2SR. Analyses of perfusate samples showed a marked decline of biochemical muscle damage markers during EVP48. Cytokine analysis disclosed an isolated increase of the proinflammatory cytokines, interleukine-6, monocyte chemotactic protein-1, and interferon-γ, during EVP and 2SR. Magnetic resonance imaging, performed after EVP48, indicated partial muscle necrosis of the intrinsic hand muscles only, while no signs for infection or inflammation were present.
Conclusion Our single case experience shows the general feasibility of an amputated limb ex vivo salvage perfusion setting to allow for delayed replantation up to 24 hours. Nevertheless, an accurate prior planning is crucial to ensure successful implementation of EVP in the acute clinical setting.
Note
This paper was presented at the 59th Annual Conference of the Austrian Society of Plastic, Aesthetic and Reconstructive Surgery (ÖGPÄRC), on October 8, 2021.
Publication History
Received: 06 June 2022
Accepted: 31 October 2022
Accepted Manuscript online:
28 December 2022
Article published online:
07 March 2023
© 2023. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)
Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA
-
References:
- 1 Blaisdell FW. The pathophysiology of skeletal muscle ischemia and the reperfusion syndrome: a review. Cardiovasc Surg 2002; 10 (06) 620-630
- 2 Krezdorn N, Macleod F, Tasigiorgos S. et al. Twenty-four-hour ex vivo perfusion with acellular solution enables successful replantation of porcine forelimbs. Plast Reconstr Surg 2019; 144 (04) 608e-618e
- 3 Ozer K, Rojas-Pena A, Mendias CL, Bryner BS, Toomasian C, Bartlett RH. The effect of ex situ perfusion in a swine limb vascularized composite tissue allograft on survival up to 24 hours. J Hand Surg Am 2016; 41 (01) 3-12
- 4 Taeger CD, Lamby P, Dolderer J. et al. Extracorporeal perfusion for salvage of major amputates. Ann Surg 2019; 270 (01) e5-e6
- 5 Haug V, Kollar B, Tasigiorgos S. et al. Hypothermic ex situ perfusion of human limbs with acellular solution for 24 hours. Transplantation 2020; 104 (09) e260-e270
- 6 Werner NL, Alghanem F, Rakestraw SL. et al. Perfusion of human limb ex situ allografts for 24 hours. Transplantation 2017; 101 (03) e68-e74
- 7 Sadaria MR, Smith PD, Fullerton DA. et al. Cytokine expression profile in human lungs undergoing normothermic ex-vivo lung perfusion. Ann Thorac Surg 2011; 92 (02) 478-484
- 8 Kueckelhaus M, Dermietzel A, Alhefzi M. et al. Acellular hypothermic extracorporeal perfusion extends allowable ischemia time in a porcine whole limb replantation model. Plast Reconstr Surg 2017; 139 (04) 922e-932e